What is the price of Hancock Jaffe Laboratories, Inc. Warrants (HJLIW)

The price of Hancock Jaffe Laboratories, Inc. Warrants (HJLIW) is $0.56

What is the market cap of Hancock Jaffe Laboratories, Inc. Warrants (HJLIW)

The market cap of Hancock Jaffe Laboratories, Inc. Warrants (HJLIW) is $3.89K

Hancock Jaffe Laboratories, Inc. Warrants

HJLIW

Rank in Stocks #42154

Share Price

$0.56

Last synced: 2021-09-30

Market Cap

$3.89K

Change (1 day)

13.41%

Change (1 year)

0.00%

Country

Trade Hancock Jaffe Laboratories, Inc. Warrants (HJLIW)

Category

Healthcare

Market Capitalization

EPS

P/E ratio for Hancock Jaffe Laboratories, Inc. Warrants (HJLIW)

P/E ratio as of 2026 TTM: 0

According to Hancock Jaffe Laboratories, Inc. Warrants latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.

P/E ratio history for Hancock Jaffe Laboratories, Inc. Warrants from 2026 to 2026

P/E ratio at the end of each year

Year	P/E Ratio	Change
Not enough data for the provided dates.

P/E ratio for similar companies or competitors

Company	P/E Ratio	P/E Ratio Difference	Country
Abbott Laboratories ABT.US	33.99	-	US
Stryker Corporation SYK.US	33.47	-	US
Medtronic plc MDT.US	21.39	-	IE
Boston Scientific Corporation BSX.US	18.84	-	US
Edwards Lifesciences Corporation EW.US	49.47	-	US

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.